Analysis of MHC immunopeptidomes using mass

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Neoantigens in cancer immunotherapy

  2015cited by this paper
• The future of immune checkpoint therapy

  2015cited by this paper
• An open-source computational and data resource to analyze digital maps of immunopeptidomes

  2015cited by this paper
• A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

  2015cited by this paper
• The ins and outs of MHC class II-mediated antigen processing and presentation

  2015cited by this paper
• A comprehensive analysis of peptides presented by HLA-A1.

  2015cited by this paper
• Teaching 'big data' analysis to young immunologists

  2015cited by this paper
• The Viral Transcription Group Determines the HLA Class I Cellular Immune Response Against Human Respiratory Syncytial Virus*

  2015cited by this paper
• Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

  2015cited by this paper
• Reproducible and Consistent Quantification of the Saccharomyces cerevisiae Proteome by SWATH-mass spectrometry*

  2015cited by this paper
• DIA-Umpire: comprehensive computational framework for data-independent acquisition proteomics

  2015cited by this paper
• Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.

  2015cited by this paper
• Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis.

  2015cited by this paper
• The ultimate mix and match: making sense of HLA alleles and peptide repertoires

  2015cited by this paper
• Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation*

  2015cited by this paper
• Advances in high‐resolution accurate mass spectrometry application to targeted proteomics

  2015cited by this paper
• Extending the Limits of Quantitative Proteome Profiling with Data-Independent Acquisition and Application to Acetaminophen-Treated Three-Dimensional Liver Microtissues*

  2015cited by this paper
• Relative Expression Levels of the HLA Class-I Proteins in Normal and HIV-Infected Cells

  2015cited by this paper
• Building high-quality assay libraries for targeted analysis of SWATH MS data

  2015cited by this paper
• Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps

  2015cited by this paper
• Using data‐independent, high‐resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications

  2015cited by this paper
• Comprehensive Analysis of the Naturally Processed Peptide Repertoire: Differences between HLA-A and B in the Immunopeptidome

  2015cited by this paper
• Revisiting the Arthritogenic Peptide Theory: Quantitative Not Qualitative Changes in the Peptide Repertoire of HLA–B27 Allotypes

  2015cited by this paper
• Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells

  2015cited by this paper
• The nature of self for T cells-a systems-level perspective.

  2015cited by this paper
• Data analysis: Create a cloud commons

  2015cited by this paper
• Biomarkers in cancer immunotherapy.

  2015cited by this paper
• Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte–Derived HLA-Ligandome Using a Reverse Immunology Approach

  2015cited by this paper
• Proteogenomics: concepts, applications and computational strategies

  2014cited by this paper
• Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

  2014cited by this paper
• Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

  2014cited by this paper
• Efficient sample processing for proteomics applications—Are we there yet?

  2014cited by this paper
• Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes.

  2014cited by this paper
• A repository of assays to quantify 10,000 human proteins by SWATH-MS

  2014cited by this paper
• Ultrasensitive proteome analysis using paramagnetic bead technology

  2014cited by this paper
• Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides

  2014cited by this paper
• Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

  2014cited by this paper
• Conserved Peptide Fragmentation as a Benchmarking Tool for Mass Spectrometers and a Discriminating Feature for Targeted Proteomics*

  2014cited by this paper
• HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)

  2014cited by this paper
• Machine learning applications in proteomics research: How the past can boost the future

  2014cited by this paper
• The nature and extent of contributions by defective ribosome products to the HLA peptidome

  2014cited by this paper
• Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells

  2014cited by this paper
• Biomedical applications of ion mobility-enhanced data-independent acquisition-based label-free quantitative proteomics

  2014cited by this paper
• Glycoproteomic Analysis of Prostate Cancer Tissues by SWATH Mass Spectrometry Discovers N-acylethanolamine Acid Amidase and Protein Tyrosine Kinase 7 as Signatures for Tumor Aggressiveness

  2014cited by this paper
• Multiplexed and data-independent tandem mass spectrometry for global proteome profiling.

  2014cited by this paper
• Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD)

  2014cited by this paper
• Technical considerations for large-scale parallel reaction monitoring analysis.

  2014cited by this paper
• The Cellular Redox Environment Alters Antigen Presentation*

  2014cited by this paper
• Unambiguous Phosphosite Localization using Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)

  2013cited by this paper
• Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach

  2013cited by this paper
• Comparison of targeted peptide quantification assays for reductive dehalogenases by selective reaction monitoring (SRM) and precursor reaction monitoring (PRM)

  2013cited by this paper
• MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

  2013cited by this paper
• Breakthrough of the year 2013. Cancer immunotherapy.

  2013cited by this paper
• The Human Leukocyte Antigen–presented Ligandome of B Lymphocytes*

  2013cited by this paper
• Recent advances in mass spectrometry: data independent analysis and hyper reaction monitoring

  2013cited by this paper
• Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes

  2013cited by this paper
• Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies

  2013cited by this paper
• Combining Results of Multiple Search Engines in Proteomics*

  2013cited by this paper
• Kinetics of Antigen Expression and Epitope Presentation during Virus Infection

  2013cited by this paper
• Biochemical large-scale identification of MHC class I ligands.

  2013cited by this paper
• Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

  2013cited by this paper
• Quantifying protein interaction dynamics by SWATH mass spectrometry: application to the 14-3-3 system

  2013cited by this paper
• DMSO enhances electrospray response, boosting sensitivity of proteomic experiments

  2013cited by this paper
• Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry.

  2013cited by this paper
• Exploring the MHC-peptide matrix of central tolerance in the human thymus

  2013cited by this paper
• HLA-Specific Intracellular Epitope Processing Shapes an Immunodominance Pattern for HLA-B*57 That Is Distinct from HLA-B*58:01

  2013cited by this paper
• SnapShot: mass spectrometry for protein and proteome analyses.

  2013cited by this paper
• Discovering naturally processed antigenic determinants that confer protective T cell immunity.

  2013cited by this paper
• Mass spectrometric protein maps for biomarker discovery and clinical research

  2013cited by this paper
• The Effect of Proteasome Inhibition on the Generation of the Human Leukocyte Antigen (HLA) Peptidome*

  2013cited by this paper
• Proteomics meets the scientific method

  2013cited by this paper
• HLA Peptide Length Preferences Control CD8+ T Cell Responses

  2013cited by this paper
• Increased Diversity of the HLA-B40 Ligandome by the Presentation of Peptides Phosphorylated at Their Main Anchor Residue*

  2013cited by this paper
• Selectivity of LC-MS/MS analysis: implication for proteomics experiments.

  2013cited by this paper
• The immune epitope database: a historical retrospective of the first decade

  2012cited by this paper
• Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands

  2012cited by this paper
• Secreted HLA recapitulates the immunopeptidome and allows in-depth coverage of HLA A*02:01 ligands.

  2012cited by this paper
• MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements.

  2012cited by this paper
• Two Preferentially Expressed Proteins Protect Vascular Endothelial Cells from an Attack by Peptide-Specific CTL

  2012cited by this paper
• Constitutive and Inflammatory Immunopeptidome of Pancreatic β-Cells

  2012cited by this paper
• Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions

  2012cited by this paper
• Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics*

  2012cited by this paper
• Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry.

  2012cited by this paper
• Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.

  2012cited by this paper
• Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis*

  2012cited by this paper
• Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

  2012cited by this paper
• Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

  2011cited by this paper
• Collision energy optimization of b- and y-ions for multiple reaction monitoring mass spectrometry.

  2011cited by this paper
• The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation

  2011cited by this paper
• The Human Immunopeptidome Project, a Suggestion for yet another Postgenome Next Big Thing

  2011cited by this paper
• Mass Spectrometry-based Proteomics Using Q Exactive, a High-performance Benchtop Quadrupole Orbitrap Mass Spectrometer*

  2011cited by this paper
• Utility of characteristic QTOF MS/MS fragmentation for MHC class I peptides.

  2011cited by this paper
• mProphet: automated data processing and statistical validation for large-scale SRM experiments

  2011cited by this paper
• Insights into MHC class I antigen processing gained from large-scale analysis of class I ligands

  2011cited by this paper
• Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600).

  2011cited by this paper
• Direct quantitation of MHC‐bound peptide epitopes by selected reaction monitoring

  2011cited by this paper
• More than 100,000 detectable peptide species elute in single shotgun proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS.

  2011cited by this paper
• NetMHCcons: a consensus method for the major histocompatibility complex class I predictions

  2011cited by this paper
• Mining the plasma immunopeptidome for cancer peptides as biomarkers and beyond

  2010cited by this paper
• Effect of collision energy optimization on the measurement of peptides by selected reaction monitoring (SRM) mass spectrometry.

  2010cited by this paper

• An automated benchmarking platform for MHC class II binding prediction methods

  2018cites this paper
• Deciphering the MHC-associated peptidome: a review of naturally processed ligand data

  2017cites this paper
• Building proteomic tool boxes to monitor MHC class I and class II peptides

  2017cites this paper